ClinicalTrials.gov
public full text
Public Domain
Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
The purpose of this study is to see if creatine, which is a naturally occurring chemical in the body, is effective for treating Major Depressive Disorder (MDD) in female teenagers. The primary hypothesis is that compared to placebo, 2g, 4g, and 10g of creatine monohydrate for eight weeks will be associated with a significant increase in brain phosphocreatine (PCr) concentrations.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Does creatine affect lipid profile? a systematic review and meta-analysis of randomized placebo-controlled trials.#220815
- Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression#966893
- N-DOSE: A Dose Optimization Trial of Nicotinamide Riboside in Parkinson's Disease#1171698
- Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism#888587
- MRS and Medication Response: A Pilot Study#916018
Record · ID 966346
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive